Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Med Chem ; 63(4): 1709-1716, 2020 02 27.
Artigo em Inglês | MEDLINE | ID: mdl-31999455

RESUMO

A hybrid of dearomatized isoprenylated acylphloroglucinol (DIAP) and monoterpenoid, hypatone A (1), together with its biosynthetic analogues 2-4 is characterized from Hypericum patulum. Structurally, 1 possesses an unprecedented spiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-2',4',6'-trione core as elucidated by extensive spectroscopic and X-ray crystallographic analyses. Biological studies reveal that compounds 1 and 2-4 produce opposite effects on Cav3.1 low voltage-gated Ca2+ channel, with 1 and 4, respectively, being the most potent Cav3.1 agonist and antagonist from natural products. Further studies suggest that compound 1 and its biogenetical precursor, 2, have the same binding site on Cav3.1 and that the rigid cagelike moiety at C-5 and C-6 is a key structural feature responsible for 1 being an agonist. Furthermore, 1 can normalize the pathological gating of a mutant Cav3.1 channel found in spinocerebellar ataxia 42 (SCA42), a hereditary neurodegenerative disorder with no available therapy. Collectively, our findings provide valuable tools for future studies on Cav3.1 physiology and pathophysiology, as well as afford possible leads for developing new drugs against SCA42, epilepsy, and pain.


Assuntos
Agonistas dos Canais de Cálcio/farmacologia , Canais de Cálcio Tipo T/metabolismo , Monoterpenos/farmacologia , Floroglucinol/análogos & derivados , Floroglucinol/farmacologia , Animais , Agonistas dos Canais de Cálcio/isolamento & purificação , Canais de Cálcio Tipo T/genética , Células HEK293 , Humanos , Hypericum/química , Ativação do Canal Iônico/efeitos dos fármacos , Potenciais da Membrana/efeitos dos fármacos , Camundongos , Monoterpenos/isolamento & purificação , Mutação , Floroglucinol/isolamento & purificação
2.
Mar Drugs ; 16(5)2018 May 16.
Artigo em Inglês | MEDLINE | ID: mdl-29772645

RESUMO

Cutaneous melanoma is the most serious type of skin cancer, so new cytotoxic weapons against novel targets in melanoma are of great interest. Euplotin C (EC), a cytotoxic secondary metabolite of the marine ciliate Euplotes crassus, was evaluated in the present study on human cutaneous melanoma cells to explore its anti-melanoma activity and to gain more insight into its mechanism of action. EC exerted a marked cytotoxic effect against three different human melanoma cell lines (A375, 501Mel and MeWo) with a potency about 30-fold higher than that observed in non-cancer cells (HDFa cells). A pro-apoptotic activity and a decrease in melanoma cell migration by EC were also observed. At the molecular level, the inhibition of the Erk and Akt pathways, which control many aspects of melanoma aggressiveness, was shown. EC cytotoxicity was antagonized by dantrolene, a ryanodine receptor (RyR) antagonist, in a concentration-dependent manner. A role of RyR as a direct target of EC was also suggested by molecular modelling studies. In conclusion, our data provide the first evidence of the anti-melanoma activity of EC, suggesting it may be a promising new scaffold for the development of selective activators of RyR to be used for the treatment of melanoma and other cancer types.


Assuntos
Organismos Aquáticos/metabolismo , Euplotes/metabolismo , Melanoma/tratamento farmacológico , Sesquiterpenos/farmacologia , Neoplasias Cutâneas/tratamento farmacológico , Apoptose/efeitos dos fármacos , Agonistas dos Canais de Cálcio/isolamento & purificação , Agonistas dos Canais de Cálcio/farmacologia , Agonistas dos Canais de Cálcio/uso terapêutico , Linhagem Celular Tumoral , Dantroleno/farmacologia , Avaliação Pré-Clínica de Medicamentos , Humanos , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Proteína Oncogênica v-akt/metabolismo , Canal de Liberação de Cálcio do Receptor de Rianodina/metabolismo , Sesquiterpenos/isolamento & purificação , Sesquiterpenos/uso terapêutico
3.
Bioorg Med Chem ; 23(13): 3761-73, 2015 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-25910586

RESUMO

Five homologs of a novel glycolipid acremomannolipin A (1a), the potential Ca(2+) signal modulator isolated from Acremonium strictum, bearing alditols of different length (1g-1k) were synthesized by a stereoselective ß-mannosylation of appropriately protected mannosyl sulfoxide (2) with five alditols (1g: C2, 1h: C3, 1i: C4, 1j: C5 and 1k: C7 units), and their potential in modulating Ca(2+) signaling were evaluated. Homologs with alditols of more than 4 carbons (1i, 1j and 1k) were equally or more potent than the parent compound (1a) regardless of the length of the alditol chain. Whereas activities of two homologs with shorter chains (1g and 1h) decreased to a considerable extent. The results indicated that the length of the alditol side chain was a crucial determinant for the potent calcium signal modulating activity.


Assuntos
Calcineurina/genética , Agonistas dos Canais de Cálcio/síntese química , Cálcio/metabolismo , Proteínas Fúngicas/genética , Glicolipídeos/síntese química , Schizosaccharomyces/metabolismo , Acremonium/química , Calcineurina/deficiência , Agonistas dos Canais de Cálcio/isolamento & purificação , Agonistas dos Canais de Cálcio/farmacologia , Sinalização do Cálcio , Proteínas Fúngicas/metabolismo , Expressão Gênica , Glicolipídeos/isolamento & purificação , Glicolipídeos/farmacologia , Transporte de Íons , Schizosaccharomyces/efeitos dos fármacos , Schizosaccharomyces/genética , Relação Estrutura-Atividade , Álcoois Açúcares/química
4.
J Appl Physiol (1985) ; 109(3): 830-9, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20576841

RESUMO

Skeletal muscle weakness is a reported ailment in individuals working in commercial hog confinement facilities. To date, specific mechanisms responsible for this symptom remain undefined. The purpose of this study was to assess whether hog barn dust (HBD) contains components that are capable of binding to and modulating the activity of type 1 ryanodine receptor Ca2+-release channel (RyR1), a key regulator of skeletal muscle function. HBD collected from confinement facilities in Nebraska were extracted with chloroform, filtered, and rotary evaporated to dryness. Residues were resuspended in hexane-chloroform (20:1) and precipitates, referred to as HBDorg, were air-dried and studied further. In competition assays, HBDorg dose-dependently displaced [3H]ryanodine from binding sites on RyR1 with an IC50 of 1.5±0.1 microg/ml (Ki=0.4±0.0 microg/ml). In single-channel assays using RyR1 reconstituted into a lipid bilayer, HBDorg exhibited three distinct dose-dependent effects: first it increased the open probability of RyR1 by increasing its gating frequency and dwell time in the open state, then it induced a state of reduced conductance (55% of maximum) that was more likely to occur and persist at positive holding potentials, and finally it irreversibly closed RyR1. In differentiated C2C12 myotubes, addition of HBD triggered a rise in intracellular Ca2+ that was blocked by pretreatment with ryanodine. Since persistent activation and/or closure of RyR1 results in skeletal muscle weakness, these new data suggest that HBD is responsible, at least in part, for the muscle ailment reported by hog confinement workers.


Assuntos
Agonistas dos Canais de Cálcio/farmacologia , Bloqueadores dos Canais de Cálcio/farmacologia , Clorofórmio/química , Poeira/análise , Abrigo para Animais , Ativação do Canal Iônico/efeitos dos fármacos , Músculo Esquelético/efeitos dos fármacos , Canal de Liberação de Cálcio do Receptor de Rianodina/efeitos dos fármacos , Solventes/química , Doenças dos Trabalhadores Agrícolas/induzido quimicamente , Animais , Sítios de Ligação , Ligação Competitiva , Cálcio/metabolismo , Agonistas dos Canais de Cálcio/efeitos adversos , Agonistas dos Canais de Cálcio/isolamento & purificação , Agonistas dos Canais de Cálcio/metabolismo , Bloqueadores dos Canais de Cálcio/efeitos adversos , Bloqueadores dos Canais de Cálcio/isolamento & purificação , Bloqueadores dos Canais de Cálcio/metabolismo , Linhagem Celular , Cromatografia em Camada Fina , Relação Dose-Resposta a Droga , Humanos , Potenciais da Membrana , Camundongos , Fibras Musculares Esqueléticas/efeitos dos fármacos , Fibras Musculares Esqueléticas/metabolismo , Debilidade Muscular/induzido quimicamente , Músculo Esquelético/metabolismo , Saúde Ocupacional , Coelhos , Medição de Risco , Rianodina/metabolismo , Canal de Liberação de Cálcio do Receptor de Rianodina/metabolismo , Sus scrofa
5.
Mol Cells ; 22(3): 328-35, 2006 Dec 31.
Artigo em Inglês | MEDLINE | ID: mdl-17202862

RESUMO

Imperatoxin A (IpTxa), a 3.7 kDa peptide from the African scorpion Pandinus imperator, is an agonist of the skeletal muscle ryanodine receptor (RyR1). In order to study the structure of the toxin and its effect on RyR1, IpTxa cDNA was PCR-amplified using 3 pairs of primers, and the toxin was expressed in E. coli. The toxin was further purified by chromatography, and various point mutants in which basic amino acids were substituted by alanine were prepared by site-directed mutagenesis. Studies of single channel properties by the planar lipid bilayer method showed that the recombinant IpTxa was identical to the synthetic IpTxa with respect to high-performance liquid chromatography mobility, amino acid composition and specific effects on RyR1. Mutations of certain basic amino acids (Lys19, Arg23, and Arg33) dramatically reduced the capacity of the peptide to activate RyRs. A subconductance state predominated when Lys8 was substituted with alanine. These results suggest that some basic amino acid residues in IpTxa are important for activation of RyR1, and that Lys8 plays an important role in regulating the gating mode of RyR1.


Assuntos
Agonistas dos Canais de Cálcio/química , Canal de Liberação de Cálcio do Receptor de Rianodina/fisiologia , Venenos de Escorpião/química , Venenos de Escorpião/genética , Substituição de Aminoácidos , Animais , Agonistas dos Canais de Cálcio/isolamento & purificação , Agonistas dos Canais de Cálcio/farmacologia , Relação Dose-Resposta a Droga , Condutividade Elétrica , Músculo Esquelético/fisiologia , Mutagênese Sítio-Dirigida , Ligação Proteica , Coelhos , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/farmacologia , Canal de Liberação de Cálcio do Receptor de Rianodina/química , Venenos de Escorpião/isolamento & purificação , Venenos de Escorpião/farmacologia , Escorpiões/química , Escorpiões/genética
6.
J Chromatogr A ; 1083(1-2): 96-101, 2005 Aug 12.
Artigo em Inglês | MEDLINE | ID: mdl-16078693

RESUMO

Sample solubility in the mobile phase and enantioselectivity are key factors in chiral preparative chromatography. In the search for a high throughput process for production of pure enantiomers, the rational design of the mobile phase and the selection of a suitable chiral stationary phase (CSP) are essential. However, one may sometimes be faced with the incompatibility between the CSP and the preferential eluent for sample solubility. Such a limitation may be circumvented by using an immobilized CSP such as CHIRALPAK IA. In this manuscript, the chiral separation of a Ca-sensitizing drug (EMD 53986) is optimized on CHIRALPAK IA in terms of sample solubility, enantioselectivity and preparative productivity. The approaches for method optimization and the impact of sample solubility on productivity are discussed. The preparative potential of CHIRALPAK IA is also demonstrated.


Assuntos
Amilose/análogos & derivados , Agonistas dos Canais de Cálcio/isolamento & purificação , Cromatografia Líquida de Alta Pressão/métodos , Fenilcarbamatos/química , Quinolinas/isolamento & purificação , Tiadiazinas/isolamento & purificação , Amilose/química , Dioxanos , Furanos , Cloreto de Metileno , Solubilidade , Estereoisomerismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...